Show simple item record

dc.contributor.authorPallis, A
dc.contributor.authorGridelli, C
dc.contributor.authorWedding, U
dc.contributor.authorFaivre-Finn, Corinne
dc.contributor.authorVeronesi, G
dc.contributor.authorJaklitsch, M
dc.contributor.authorLuciani, A
dc.contributor.authorO'Brien, M
dc.date.accessioned2014-09-22T08:57:29Z
dc.date.available2014-09-22T08:57:29Z
dc.date.issued2014-07
dc.identifier.citationManagement of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology. 2014, 25 (7):1270-83 Ann Oncolen
dc.identifier.issn1569-8041
dc.identifier.pmid24638905
dc.identifier.doi10.1093/annonc/mdu022
dc.identifier.urihttp://hdl.handle.net/10541/326326
dc.description.abstractNon-small-cell lung cancer (NSCLC) is a very common disease in the elderly population and its incidence in this particular population is expected to increase further, because of the ageing of the Western population. Despite this, limited data are available for the treatment of these patients and, therefore, the development of evidence-based treatment recommendations is challenging. In 2010, European Organization for Research and Treatment of Cancer (EORTC) took an initiative in collaboration with International Society of Geriatric Oncology (SIOG) and created an experts panel that provided an experts' opinion consensus paper for the management of elderly NSCLC patients. Since this publication, important new data are available and EORTC and SIOG recommended to update the 2010 recommendations. Besides recommendations for surgery, adjuvant chemotherapy and radiotherapy, treatment of locally advanced and metastatic disease, recommendations were expanded, to include data on patient preferences and geriatric assessment.
dc.language.isoenen
dc.rightsArchived with thanks to Annals of oncology : official journal of the European Society for Medical Oncology / ESMOen
dc.titleManagement of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.en
dc.typeArticleen
dc.contributor.departmentMedical Department, European Organization for Research and Treatment of Cancer, Brussels, Belgiumen
dc.identifier.journalAnnals of Oncologyen
refterms.dateFOA2020-04-03T11:30:47Z
html.description.abstractNon-small-cell lung cancer (NSCLC) is a very common disease in the elderly population and its incidence in this particular population is expected to increase further, because of the ageing of the Western population. Despite this, limited data are available for the treatment of these patients and, therefore, the development of evidence-based treatment recommendations is challenging. In 2010, European Organization for Research and Treatment of Cancer (EORTC) took an initiative in collaboration with International Society of Geriatric Oncology (SIOG) and created an experts panel that provided an experts' opinion consensus paper for the management of elderly NSCLC patients. Since this publication, important new data are available and EORTC and SIOG recommended to update the 2010 recommendations. Besides recommendations for surgery, adjuvant chemotherapy and radiotherapy, treatment of locally advanced and metastatic disease, recommendations were expanded, to include data on patient preferences and geriatric assessment.


Files in this item

Thumbnail
Name:
Management of elderly patients ...
Size:
228.4Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record